NLS

At the 2026 JPM Conference, Lilly and Nvidia announced an expanded AI partnership, including a USD 1 billion co‑innovation lab in the Bay Area to integrate advanced computing and biology for drug discovery.

When working, many of us sit for long periods of time, especially at desks and in front of screens.

The companies have obtained a EUR 1.3 million EU grant reward under the Eurostars program to advance an orally administered anti‑HER2 antibody, Trastuzimab, for treatment of breast cancer

Wegovy pill was approved on December 22, 2025 and is used with a reduced calorie diet and increased physical activity for adults with obesity, or with overweight who also have weight-related medical problems, to help them lose weight and keep it off.

The company has raised EUR 5 million of new funding from new and existing investors via a EUR 9 million convertible bond issuance.

Elicera Therapeutics has announced final data from its Phase I/IIa clinical trial evaluating the oncolytic virus ELC-100 in patients with advanced, end-stage neuroendocrine tumors who had exhausted all currently available therapeutic options and having progressing diseases.